Hepatitis
Latest News
A decade after first DAA, only one in three are HCV free
Patients face barriers to being cured at every step of the way, from being diagnosed to accessing breakthrough DAA agents.
Latest News
NAFLD increases risk for severe infections
Physicians should assess their patients’ vaccination status and seek to control modifiable risk factors, such as diabetes.
Latest News
Dried blood spot test validated for HIV, hep B, and hep C
“This method is particularly useful in high-risk settings such as homeless shelters, drug rehabilitation centers, and prisons, where ... it can be...
From the Journals
Racial disparities not found in chronic hepatitis B treatment initiation
Treatment guidelines need to be simplified and that efforts to increase hepatitis B virus (HBV) awareness and train more clinicians are needed.
From the Journals
Likely cause of mysterious hepatitis outbreak in children identified
The study’s key messages for parents and health care providers “are awareness and reassurance,” Dr. Balistreri said in an interview.
Commentary
Celebrity death finally solved – with locks of hair
Case: A 56-year-old musician presents with diffuse abdominal pain, cramping, and jaundice. His medical history is notable for years of diffuse...
From the Journals
CDC recommends screening all adults for hepatitis B
“Risk-based testing alone has not identified most persons living with chronic HBV infection and is considered inefficient for providers to...
Latest News
NICU use up, birth weights down in babies of mothers with HCV
New findings surprised a study researcher since the adverse outcomes weren’t related to prematurity.
Commentary
The five biggest changes in the 2023 adult vaccine schedules
COVID vaccines are now front and center among 2023’s five most important changes.
From the Journals
Strong support to provide DAA therapy to all patients with HCV
The findings highlight a “substantial need to provide DAA therapy to all patients with HCV, regardless of disease stage or financial status.”
Feature
Direct-acting antivirals tied to better outcomes in chronic Hep C
Researchers saw a significant reduction in all-cause mortality over a decade with direct-acting antivirals compared with no treatment.